SMS Pharmaceuticals Share Price
SMS Pharmaceuticals Share Price Today
As of 5 Jul 2026, SMS Pharmaceuticals share price is ₹421.45. The stock opened at ₹420.10, compared to its previous close of ₹417.65. During today's trading session, SMS Pharmaceuticals share price moved in the range of ₹413.25 to ₹424.80, with an average price of ₹419.02 for the day. Looking at its last 52-week, the stock has touched a low of ₹207.99 and a high of ₹447.80. On the performance front, SMS Pharmaceuticals share price has increased by 29.18% over the last six months and is up 74.73% on a year-on-year basis.
SMS Pharmaceuticals Returns Calculator
SMS Pharmaceuticals Shareholder Returns
SMS Pharmaceuticals Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
SMS Pharmaceuticals Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹782.75 | ₹709.26 | ₹522.05 | ₹519.87 |
| Other Income | ₹6.22 | ₹4.46 | ₹4.91 | ₹5.20 |
| Total Revenue | ₹788.97 | ₹713.72 | ₹526.97 | ₹525.07 |
| Total Expenses | ₹696.64 | ₹647.62 | ₹521.62 | ₹456.57 |
| Profit Before Tax | ₹92.34 | ₹66.11 | ₹5.35 | ₹68.50 |
| Tax | ₹24.94 | ₹16.91 | ₹1.47 | ₹0.62 |
| Profit After Tax | ₹67.40 | ₹49.20 | ₹3.88 | ₹67.88 |
| EPS - Basic | ₹8.16 | ₹5.89 | -₹0.83 | ₹7.35 |
| EPS - Diluted | ₹8.16 | ₹5.89 | -₹0.83 | ₹7.35 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹92.34 | ₹66.11 | ₹5.35 | ₹68.50 |
| Income before WC changes | ₹144.62 | ₹120.07 | ₹58.34 | ₹118.36 |
| Change in Assets | -₹13.39 | -₹106.90 | -₹72.70 | -₹60.34 |
| Change in Liabilities | -₹29.69 | ₹52.35 | ₹41.41 | ₹1.96 |
| Change in WC | -₹43.08 | -₹54.55 | -₹31.29 | -₹58.38 |
| Cash flow from Operations | ₹81.71 | ₹50.12 | ₹22.45 | ₹45.06 |
| Cash flow from Investing | -₹123.43 | -₹52.07 | -₹29.76 | -₹27.15 |
| Cash flow from Financing | ₹47.08 | ₹30.68 | -₹31.97 | -₹11.75 |
| Total Cash Flow | ₹5.36 | ₹28.73 | -₹39.28 | ₹6.16 |
| Cash (Start of the year) | ₹36.04 | ₹7.31 | ₹46.58 | ₹40.42 |
| Cash (End of the year) | ₹41.40 | ₹36.04 | ₹7.31 | ₹46.58 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹598.21 | ₹500.20 | ₹468.96 | ₹482.45 |
| Current Assets | ₹554.47 | ₹533.89 | ₹410.65 | ₹377.05 |
| Total Assets | ₹1,152.68 | ₹1,034.09 | ₹879.61 | ₹859.50 |
| Current Liabilities | ₹324.37 | ₹331.72 | ₹254.91 | ₹196.48 |
| Net Current Asset | ₹230.10 | ₹202.18 | ₹155.74 | ₹180.57 |
| Non-Current Liabilities | ₹188.67 | ₹166.05 | ₹164.17 | ₹192.73 |
| Equity Capital | ₹639.64 | ₹536.33 | ₹460.53 | ₹470.29 |
| Total Equity & Liabilities | ₹1,152.68 | ₹1,034.09 | ₹879.61 | ₹859.50 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹782.75 | ₹709.26 | ₹522.05 | ₹519.87 |
| Other Income | ₹6.22 | ₹4.46 | ₹4.91 | ₹5.20 |
| Total Revenue | ₹788.97 | ₹713.72 | ₹526.97 | ₹525.07 |
| Total Expenses | ₹695.65 | ₹647.39 | ₹521.42 | ₹456.42 |
| Profit Before Tax | ₹93.32 | ₹66.33 | ₹5.55 | ₹68.65 |
| Tax | ₹24.94 | ₹16.91 | ₹1.47 | ₹0.62 |
| Profit After Tax | ₹68.38 | ₹49.42 | ₹4.08 | ₹68.04 |
| EPS - Basic | ₹8.07 | ₹5.84 | ₹0.48 | ₹8.04 |
| EPS - Diluted | ₹8.07 | ₹5.84 | ₹0.48 | ₹8.04 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹93.32 | ₹66.33 | ₹5.55 | ₹68.65 |
| Income before WC changes | ₹144.63 | ₹120.07 | ₹58.34 | ₹118.36 |
| Change in Assets | -₹13.39 | -₹106.90 | -₹72.70 | -₹60.34 |
| Change in Liabilities | -₹29.69 | ₹52.35 | ₹41.41 | ₹1.96 |
| Change in WC | -₹43.08 | -₹54.55 | -₹31.29 | -₹58.38 |
| Cash flow from Operations | ₹81.71 | ₹50.12 | ₹22.45 | ₹45.06 |
| Cash flow from Investing | -₹123.44 | -₹52.07 | -₹29.76 | -₹27.15 |
| Cash flow from Financing | ₹47.08 | ₹30.68 | -₹31.97 | -₹11.75 |
| Total Cash Flow | ₹5.35 | ₹28.73 | -₹39.28 | ₹6.16 |
| Cash (Start of the year) | ₹36.04 | ₹7.31 | ₹46.58 | ₹40.42 |
| Cash (End of the year) | ₹41.39 | ₹36.04 | ₹7.31 | ₹46.58 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹631.64 | ₹534.36 | ₹503.54 | ₹505.92 |
| Current Assets | ₹554.46 | ₹533.89 | ₹410.65 | ₹377.05 |
| Total Assets | ₹1,186.10 | ₹1,068.25 | ₹914.18 | ₹882.97 |
| Current Liabilities | ₹324.36 | ₹331.72 | ₹254.91 | ₹196.48 |
| Net Current Asset | ₹230.10 | ₹202.18 | ₹155.74 | ₹180.57 |
| Non-Current Liabilities | ₹188.67 | ₹166.05 | ₹164.17 | ₹192.73 |
| Equity Capital | ₹673.07 | ₹570.49 | ₹495.10 | ₹493.76 |
| Total Equity & Liabilities | ₹1,186.10 | ₹1,068.25 | ₹914.18 | ₹882.97 |
About SMS Pharmaceuticals
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
SMS Pharmaceuticals Financial Highlights
- Revenue: SMS Pharmaceuticals reported revenue of ₹895.22 crore in FY26 vs ₹788.97 crore in FY25. It showed an increase of 13.47% on a yearly basis.
- Operating Profit: SMS Pharmaceuticals reported an operating profit of ₹116.64 crore in FY26 vs ₹92.34 crore in FY25. It showed an increase of 26.32% on a year-on-year basis.
- Net Profit: SMS Pharmaceuticals reported a net profit of ₹88.00 crore in FY26 vs ₹67.40 crore in FY25. It showed an increase of 30.56% on a yearly basis.
SMS Pharmaceuticals Quarterly Result Highlights
- SMS Pharmaceuticals reported revenue of ₹240.52 crore in Mar 2026, compared with ₹214.20 crore in Dec 2025, representing an increase of 12.29% on a quarter-on-quarter (QoQ) basis.
- SMS Pharmaceuticals reported an operating profit of ₹27.07 crore in Mar 2026, compared with ₹31.16 crore in Dec 2025, representing a decrease of 13.13% on a quarter-on-quarter (QoQ) basis.
- SMS Pharmaceuticals reported a profit of ₹20.96 crore in Mar 2026, compared with ₹23.19 crore in Dec 2025, reflecting a decrease of 9.62% on a QoQ basis.
- The earnings per share (EPS) of SMS Pharmaceuticals stood at ₹8.16 during Mar 2026.
Similar Stocks
FAQs on SMS Pharmaceuticals Share Price
What is SMS Pharmaceuticals share price today?
SMS Pharmaceuticals share price is ₹421.45 as on 03 Jul, 2026, 15:43 IST.
How has the SMS Pharmaceuticals share price performed in the past?
In the last 1 year, SMS Pharmaceuticals delivered a return of 74.73%. The SMS Pharmaceuticals share price hit a high of ₹447.80 and low of ₹207.99.
How much is the Mutual Fund shareholding in SMS Pharmaceuticals shares?
The Mutual Fund Shareholding in SMS Pharmaceuticals was 2.96% at the end of Mar 2026.
What is the the 52-week high and low of SMS Pharmaceuticals shares ?
The 52-week high and low of SMS Pharmaceuticals share is ₹447.80 and ₹207.99 as of 03 Jul, 2026.
What is the market cap of SMS Pharmaceuticals?
The market capitalisation of SMS Pharmaceuticals is ₹3,909.97 Crores as on 03 Jul, 2026.
What are the stock symbols of SMS Pharmaceuticals?
The stock symbol of SMS Pharmaceuticals is SMSPHARMA on the NSE, 532815 on the BSE, and the ISIN is INE812G01025.
What was yesterday's closing price of SMS Pharmaceuticals shares ?
SMS Pharmaceuticals shares closed yesterday at ₹417.65 on NSE & ₹417.50 on BSE
How to buy SMS Pharmaceuticals shares?
To buy SMS Pharmaceuticals shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy SMS Pharmaceuticals shares on Holidays?
No, shares of SMS Pharmaceuticals or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell SMS Pharmaceuticals shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of SMS Pharmaceuticals?
The PE and PB ratio of SMS Pharmaceuticals is 38.34 and 4.98 respectively, as on 03 Jul, 2026, 15:43 IST.